These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 8375833

  • 21. A five year follow-up study of the use of clozapine in community practice.
    Drew LR, Griffiths KM, Hodgson DM.
    Aust N Z J Psychiatry; 2002 Dec; 36(6):780-6. PubMed ID: 12406120
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of clozapine treatment in therapy-refractory schizophrenia.
    Jonsson D, Wålinder J.
    Acta Psychiatr Scand; 1995 Sep; 92(3):199-201. PubMed ID: 7484198
    [Abstract] [Full Text] [Related]

  • 23. Experience with clozapine in a community mental health care setting.
    Connelly JC, Fullick J.
    South Med J; 1998 Sep; 91(9):838-41. PubMed ID: 9743054
    [Abstract] [Full Text] [Related]

  • 24. Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec.
    Latimer E, Wynant W, Clark R, Malla A, Moodie E, Tamblyn R, Naidu A.
    Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):33-41. PubMed ID: 23367500
    [Abstract] [Full Text] [Related]

  • 25. A two-year clinical and economic follow-up of patients on clozapine.
    Honigfeld G, Patin J.
    Hosp Community Psychiatry; 1990 Aug; 41(8):882-5. PubMed ID: 2401478
    [Abstract] [Full Text] [Related]

  • 26. Health status and health care costs for publicly funded patients with schizophrenia started on clozapine.
    Blieden N, Flinders S, Hawkins K, Reid M, Alphs LD, Arfken CL.
    Psychiatr Serv; 1998 Dec; 49(12):1590-3. PubMed ID: 9856622
    [Abstract] [Full Text] [Related]

  • 27. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R, Cramer J, Xu W, Grabowski J, Douyon R, Thomas J, Henderson W, Charney D.
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219
    [Abstract] [Full Text] [Related]

  • 28. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
    Remington GJ, Addington D, Collins EJ, Jones BD, Lalonde P, MacCrimmon DJ, MacEwan GW.
    Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
    [Abstract] [Full Text] [Related]

  • 29. Health care costs of therapy-refractory schizophrenic patients treated with clozapine: a study in a community psychiatric service in Italy.
    Percudani M, Fattore G, Galletta J, Mita PL, Contini A, Altamura AC.
    Acta Psychiatr Scand; 1999 Apr; 99(4):274-80. PubMed ID: 10223430
    [Abstract] [Full Text] [Related]

  • 30. Cost-effectiveness of clozapine therapy for severe psychosis.
    Ghaemi SN, Ziegler DM, Peachey TJ, Goodwin FK.
    Psychiatr Serv; 1998 Jun; 49(6):829-31. PubMed ID: 9634167
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.
    Meltzer HY, Cola P, Way L, Thompson PA, Bastani B, Davies MA, Snitz B.
    Am J Psychiatry; 1993 Nov; 150(11):1630-8. PubMed ID: 8105705
    [Abstract] [Full Text] [Related]

  • 33. Cost of monitoring clozapine.
    Eilers R.
    Hosp Community Psychiatry; 1991 Sep; 42(9):955-6. PubMed ID: 1743673
    [No Abstract] [Full Text] [Related]

  • 34. The Business Case for Expanded Clozapine Utilization.
    Gören JL, Rose AJ, Smith EG, Ney JP.
    Psychiatr Serv; 2016 Nov 01; 67(11):1197-1205. PubMed ID: 27301766
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A clozapine treatment program for patients living in the community.
    O'Connor FW, Sprunger JE, Petry SD.
    Hosp Community Psychiatry; 1992 Sep 01; 43(9):909-11. PubMed ID: 1427699
    [Abstract] [Full Text] [Related]

  • 37. Clozapine in community practice: a 3-year follow-up study in the Australian Capital Territory.
    Drew LR, Hodgson DM, Griffiths KM.
    Aust N Z J Psychiatry; 1999 Oct 01; 33(5):667-75. PubMed ID: 10544990
    [Abstract] [Full Text] [Related]

  • 38. Clozapine for refractory schizophrenia: the Illinois experience.
    Buckman RW, Malan RD.
    J Clin Psychiatry; 1999 Oct 01; 60 Suppl 1():18-22; discussion 28-30. PubMed ID: 10037166
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM, Singh P, Shepherd CJ, Puthiryackal J.
    Clin Schizophr Relat Psychoses; 2010 Apr 01; 4(1):49-55. PubMed ID: 20643629
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.